Overview

Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis

Status:
Completed

Trial end date:
2010-07-01

Target enrollment:

Participant gender:

Summary

Prospective, non-randomized, multi-center study to assess the efficacy and safety of paricalcitol injection or oral administered over 6 months to patients with secondary hyperparathyroidism on dialysis.

Phase:

Phase 4

Details

Lead Sponsor:

Abbott

Treatments:

Ergocalciferols